| Authors: |
Gordon BK; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Muhowski EM; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio., Singh J; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Ravikrishnan J; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Peris-Cuesta A; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Diaz Rohena D; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Sanchez JR; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Thangavadivel S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Benrashid S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., He A; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Marr AR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Mitchell AD; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio., Urrutia JM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Misra S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Lai TH; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Yu L; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio., Walker BR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Perry E; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Shukla SA; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Grieselhuber NR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Rogers KA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Lapalombella R; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Blachly JS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Kittai AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Bhat SA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Jain N; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Wierda WG; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio., Niesman M; MingSight Pharmaceuticals Inc., San Diego, California., Zhang K; MingSight Pharmaceuticals Inc., San Diego, California., Sampath D; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. |
